Elevated plasma homocysteine level is not primarily related to Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 34, Issue 2, 2012, Pages 121-127

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cobalamin; Creatinine; Folate; Homocysteine; Mild cognitive impairment; Vascular disease

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RENAL INSUFFICIENCY; RISK FACTORS; VASCULAR DISEASES; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84866482141     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000342612     Document Type: Article

References (40)

1. Regland B, Abrahamsson L, Gottfries CG, Magnus E: Vitamin B12 analogous, homocysteine, methylmalonic acid and transcobalamins in the study of vitamin B12 deficiency in primary degenerative dementia. Dement Geriatr Cogn Disord 1990;1:272-277.
2. van Dam F, van Gool WA: Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Arch Gerontol Geriatr 2009;48: 425-430.
3. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
4. Seshadri S: Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 2006;9:393-398.
5. Zhuo JM, Wang H, Pratico D: Is hyperhomocysteinemia an (AD) risk factor and AD marker, or neither? Trends Pharmacol Sci 2011;32:562-571.
6. Refsum H, Smith DA, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
7. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-641.
8. Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I: Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006; 29:3-20.
9. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325: 1202-1209.
10. Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: a meta analysis. JAMA 2002; 288:2015-2022.
11. Allen LH: How common is vitamin B12 deficiency? Am J Clin Nutr 2009;89:693S-696S.
12. Obeid R, McCaddon A, Herrmann W: The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007;45: 1590-1606.
13. Coppede F: One-carbon metabolism and Alzheimer's disease: focus on epigenetics. Curr Genomics 2010;11:246-260.
14. Elshorbagy AK, Oulhaj A, Konstantinova S, Nurk E, Ueland PM, Tell GS, Nygard O, Vollset SE, Refsum H: Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: use of statistical modelling to determine reference limits. Clin Biochem 2007;40:1209-1218.
15. van Guldener C: Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant 2006;21:1161-1166.
16. Norlund L, Grubb A, Fex G, Leksell H, Nilsson J-E, Schenk H, Hultberg B: The increase of plasma homocysteine concentration with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998;36:175-178.
17. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. Dement Geriatr Cogn Disord 2006:22:358-366.
18. Nilsson K, Gustafson L, Hultberg B: Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis. Dement Geriatr Cogn Disord 2007;24:162-168.
19. Nilsson K, Gustafson L, Hultberg B: Survival in a large population of patients with dementia and other forms of psychogeriatric diseases. Dement Geriatr Cogn Disord 2011;32: 342-350.
20. Gauthier S, Reisberg B, Zaudig M, et al: Mild cognitive impairment. Lancet 2006;367: 1262-1270.
21. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256: 183-194.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 (DSM-IV). Washington, American Psychiatric Association, 1994.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan M: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
24. Nilsson K, Gustafson L, Faldt R, Andersson A, Brattstrom L, Lindgren A, Israelsson B, Hultberg B: Hyperhomocysteinemia - a common finding in a psychogeriatric population. Eur J Clin Invest 1996;26:853-859.
25. Andersson A, Isaksson A, Brattstrom L, Hultberg B: Homocysteine and other thiols determined in plasma by HPLC and thiolspecific postcolumn derivatization. Clin Chem 1993;39:1590-1597.
26. Hultberg B, Nilsson K, I saksson A, Gustafson L: Folate deficiency is a common finding in psychogeriatric patients. Aging Clin Exp Res 2002;14:479-484.
27. Clarke R, Evans JG, Schneede J, Nexo E, Bates C, Fletcher A, Prentice A, Johnston C, Ueland PM, Refsum H, Sherliker P, Birks J, Whitlock G, Breeze E, Scott JM: Vitamin B12 and folate deficiency in later life. Age Ageing 2004;33:34-41.
28. Nilsson K, Gustafson L, Hultberg B: The use of N-terminal pro-brain natriuretic peptide to evaluate vascular disease in elderly patients with mental illness. Dement Geriatr Cogn Dis Extra 2012;2:10-18.
29. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-1455.
30. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F: Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am J Clin Nutr 2005;82:636-643.
31. Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, Smith AD: Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry 2010;25:82-90.
32. Nilsson K, Gustafson L, Hultberg B: Relation between plasma homocysteine and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:7-12.
33. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 19:666-672.
34. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease. Dement Geriatr Cogn Disord 2007;23: 321-326.
35. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, Chodalowoska-Zebrowska M, Wasiak B, Peplonska B, Barcikowska M: The rate of conversion of mild cognitive impairment to dementia: predictive role depression. Int J Geriatr Psychiatry 2007;22:563-567.
36. Vogel T, Dali-Youcef N, Kaltenbach G, Andres E: Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. J Clin Pract 2009;63: 1061-1067.
37. Wald DS, Kasturiatne A, Simmonds M: Effects of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med 2010;123: 1320-1326.
38. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH: High dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008;300:1774-1783.
39. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P: Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369:208-216.
40. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD: Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 2012;27:592-600.